113 related articles for article (PubMed ID: 15229896)
1. Crystal structures of Staphylococcus aureus type I dehydroquinase from enzyme turnover experiments.
Nichols CE; Lockyer M; Hawkins AR; Stammers DK
Proteins; 2004 Aug; 56(3):625-8. PubMed ID: 15229896
[No Abstract] [Full Text] [Related]
2. The two types of 3-dehydroquinase have distinct structures but catalyze the same overall reaction.
Gourley DG; Shrive AK; Polikarpov I; Krell T; Coggins JR; Hawkins AR; Isaacs NW; Sawyer L
Nat Struct Biol; 1999 Jun; 6(6):521-5. PubMed ID: 10360352
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.
Robinson DA; Stewart KA; Price NC; Chalk PA; Coggins JR; Lapthorn AJ
J Med Chem; 2006 Feb; 49(4):1282-90. PubMed ID: 16480265
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different crystal forms of 3-dehydroquinase from Salmonella typhi and its implication for the enzyme activity.
Lee WH; Perles LA; Nagem RA; Shrive AK; Hawkins A; Sawyer L; Polikarpov I
Acta Crystallogr D Biol Crystallogr; 2002 May; 58(Pt 5):798-804. PubMed ID: 11976491
[TBL] [Abstract][Full Text] [Related]
5. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
[TBL] [Abstract][Full Text] [Related]
6. 2-substituted-3-dehydroquinic acids as potent competitive inhibitors of type II dehydroquinase.
Prazeres VF; Castedo L; Lamb H; Hawkins AR; González-Bello C
ChemMedChem; 2009 Dec; 4(12):1980-4. PubMed ID: 19856378
[No Abstract] [Full Text] [Related]
7. Crystal structure of the type II 3-dehydroquinase from Helicobacter pylori.
Lee BI; Kwak JE; Suh SW
Proteins; 2003 Jun; 51(4):616-7. PubMed ID: 12784220
[No Abstract] [Full Text] [Related]
8. Structural and functional characterization of Staphylococcus aureus dihydrodipicolinate synthase.
Girish TS; Sharma E; Gopal B
FEBS Lett; 2008 Aug; 582(19):2923-30. PubMed ID: 18671976
[TBL] [Abstract][Full Text] [Related]
9. Crystallization of a type I 3-dehydroquinase from Salmonella typhi.
Boys CW; Bury SM; Sawyer L; Moore JD; Charles IG; Hawkins AR; Deka R; Kleanthous C; Coggins JR
J Mol Biol; 1992 Sep; 227(1):352-5. PubMed ID: 1522599
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of Trypanosoma brucei and Staphylococcus aureus mevalonate diphosphate decarboxylase inform on the determinants of specificity and reactivity.
Byres E; Alphey MS; Smith TK; Hunter WN
J Mol Biol; 2007 Aug; 371(2):540-53. PubMed ID: 17583736
[TBL] [Abstract][Full Text] [Related]
11. Insights into substrate binding and catalysis in bacterial type I dehydroquinase.
Maneiro M; Peón A; Lence E; Otero JM; Van Raaij MJ; Thompson P; Hawkins AR; González-Bello C
Biochem J; 2014 Sep; 462(3):415-24. PubMed ID: 24957267
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of YagE, a putative DHDPS-like protein from Escherichia coli K12.
Manicka S; Peleg Y; Unger T; Albeck S; Dym O; Greenblatt HM; Bourenkov G; Lamzin V; Krishnaswamy S; Sussman JL
Proteins; 2008 Jun; 71(4):2102-8. PubMed ID: 18361457
[No Abstract] [Full Text] [Related]
13. Chemical Modification of a Dehydratase Enzyme Involved in Bacterial Virulence by an Ammonium Derivative: Evidence of its Active Site Covalent Adduct.
González-Bello C; Tizón L; Lence E; Otero JM; van Raaij MJ; Martinez-Guitian M; Beceiro A; Thompson P; Hawkins AR
J Am Chem Soc; 2015 Jul; 137(29):9333-43. PubMed ID: 26148116
[TBL] [Abstract][Full Text] [Related]
14. Structure of CDP-D-glucose 4,6-dehydratase from Salmonella typhi complexed with CDP-D-xylose.
Koropatkin NM; Holden HM
Acta Crystallogr D Biol Crystallogr; 2005 Apr; 61(Pt 4):365-73. PubMed ID: 15805590
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of bifunctional inhibitors of type II dehydroquinase.
Toscano MD; Frederickson M; Evans DP; Coggins JR; Abell C; González-Bello C
Org Biomol Chem; 2003 Jun; 1(12):2075-83. PubMed ID: 12945898
[TBL] [Abstract][Full Text] [Related]
16. Irreversible covalent modification of type I dehydroquinase with a stable Schiff base.
Tizón L; Maneiro M; Peón A; Otero JM; Lence E; Poza S; van Raaij MJ; Thompson P; Hawkins AR; González-Bello C
Org Biomol Chem; 2015 Jan; 13(3):706-16. PubMed ID: 25370445
[TBL] [Abstract][Full Text] [Related]
17. Irreversible inhibition of type I dehydroquinase by substrates for type II dehydroquinase.
Bello CG; Harris JM; Manthey MK; Coggins JR; Abell C
Bioorg Med Chem Lett; 2000 Mar; 10(5):407-9. PubMed ID: 10743936
[TBL] [Abstract][Full Text] [Related]
18. Structural insight into substrate binding and catalysis of a novel 2-keto-3-deoxy-D-arabinonate dehydratase illustrates common mechanistic features of the FAH superfamily.
Brouns SJ; Barends TR; Worm P; Akerboom J; Turnbull AP; Salmon L; van der Oost J
J Mol Biol; 2008 May; 379(2):357-71. PubMed ID: 18448118
[TBL] [Abstract][Full Text] [Related]
19. Dynamic elements govern the catalytic activity of CapE, a capsular polysaccharide-synthesizing enzyme from Staphylococcus aureus.
Miyafusa T; Caaveiro JM; Tanaka Y; Tsumoto K
FEBS Lett; 2013 Nov; 587(23):3824-30. PubMed ID: 24157361
[TBL] [Abstract][Full Text] [Related]
20. Domain organization and crystal structure of the catalytic domain of E.coli RluF, a pseudouridine synthase that acts on 23S rRNA.
Sunita S; Zhenxing H; Swaathi J; Cygler M; Matte A; Sivaraman J
J Mol Biol; 2006 Jun; 359(4):998-1009. PubMed ID: 16712869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
